Pathways to new drug discovery in neuropsychiatry
<p>Abstract</p> <p>There is currently a crisis in drug discovery for neuropsychiatric disorders, with a profound, yet unexpected drought in new drug development across the spectrum. In this commentary, the sources of this dilemma and potential avenues to redress the issue are explo...
Main Author: | Berk Michael |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2012-11-01
|
Series: | BMC Medicine |
Subjects: | |
Online Access: | http://www.biomedcentral.com/1741-7015/10/151 |
Similar Items
-
Treatment-resistant bipolar depression: concepts and challenges for novel interventions
by: Alexandre P. Diaz, et al.
Published: (2021-05-01) -
Possibility of a New Indication for Amantadine in the Treatment of Bipolar Depression—Case Series Study
by: Marek Krzystanek, et al.
Published: (2020-10-01) -
Non-canonical pathways in the pathophysiology and therapeutics of bipolar disorder
by: Rodrigo Machado-Vieira, et al.
Published: (2023-08-01) -
New Trends in Aging Drug Discovery
by: Bellinda Benhamú, et al.
Published: (2022-08-01) -
A brief review of exercise, bipolar disorder and mechanistic pathways
by: Daniel eThomson, et al.
Published: (2015-03-01)